XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors - Related Studies

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

This study has been terminated.

Study NCT00090025. Last updated on January 2, 2007. Information provided by Helsinn Healthcare SA

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Biliary Tract Cancer

2	Additional conditions recognized in this trial
		Biliary Tract Neoplasms

3	More general conditions related to this trial
		Biliary Tract Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		XL119
		5-Fluorouracil and Leucovorin

5	Additional drug interventions recognized in this trial
		Fluorouracil
		Leucovorin

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		Helsinn Healthcare SA